| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2001 | CN1298444A Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/06/2001 | CN1298411A Caspase-8 interacting proteins |
| 06/06/2001 | CN1298409A 20-keto-11&beta, -arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 06/06/2001 | CN1298406A Condensed thienopyrimidines with phosphodiesterase-V inhibiting action |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1298403A Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 06/06/2001 | CN1298402A Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 06/06/2001 | CN1298398A 12,13-modified epothilone derivatives |
| 06/06/2001 | CN1298396A N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
| 06/06/2001 | CN1298394A Aryl fused azapolycyclic compounds |
| 06/06/2001 | CN1298393A Quinoline derivatives |
| 06/06/2001 | CN1298391A 1-[(1-substituted-4-piperidinyl) methyl]-4-piperidine derivatives, process for producing the same medicinal compositions containing the same and intermediate of these compounds |
| 06/06/2001 | CN1298389A Cyclic amino compounds |
| 06/06/2001 | CN1298387A Process for the preparation of methyl (2S)-2-[(3R)-3-CN-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yL] propionate |
| 06/06/2001 | CN1298386A N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders |
| 06/06/2001 | CN1298383A Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds |
| 06/06/2001 | CN1298318A Chelate-foming filter, process for producing the same, and method of purifying liquid with the filter |
| 06/06/2001 | CN1298311A A drug composition containing sodium Pravastatin |
| 06/06/2001 | CN1298310A Stable mitoxantron solutions |
| 06/06/2001 | CN1298309A Method for treating painful conditions of the anal region and compositions therefor |
| 06/06/2001 | CN1298306A Treatment of i (C. Difficile) toxin B associated conditions |
| 06/06/2001 | CN1298305A Interleukin-6 production inhibitors |
| 06/06/2001 | CN1298304A Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 06/06/2001 | CN1298303A Stable compositions comprising levosimendan and alginic acid |
| 06/06/2001 | CN1298302A Topical administration of oxazolidinones for transdermal delivery |
| 06/06/2001 | CN1298301A Treatment of generalized anxiety disorder with paroxetine |
| 06/06/2001 | CN1298300A Fire-resistant non-explosive solid mixtures containing nitroglycerine and water-free lactose |
| 06/06/2001 | CN1298299A Antibacterial agents |
| 06/06/2001 | CN1298297A Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 06/06/2001 | CN1298295A Method and compositions for stabilizing acetylcholine compositions |
| 06/06/2001 | CN1298294A Nicotine inhaler |
| 06/06/2001 | CN1298291A Anhydrous aerosol hairspray compositions containing silicone grafted copolymers |
| 06/06/2001 | CN1298290A Use of retinoic acid activity inhibitors to slow down hair loss |
| 06/06/2001 | CN1298020A CD3-resisting single clone antibody heavy-chain and light-chain variable-area gene and its application |
| 06/06/2001 | CN1297890A Matrine and inorganic salt of matrinidine and their preparation |
| 06/06/2001 | CN1297888A 2-(3,5-=-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-radical-4-o-tolyl-pyridine-3-radical)-isobutyryl |
| 06/06/2001 | CN1297887A Process for producing pyridine derivate |
| 06/06/2001 | CN1297778A New drug form for human body cavity and its implementation |
| 06/06/2001 | CN1297775A Cultivation of bezoar for oral veterinary medicine chenghuangling and its preparing method |
| 06/06/2001 | CN1297767A External-use burn ointment |
| 06/06/2001 | CN1297757A Medicine liquid for treating pain of injury |
| 06/06/2001 | CN1297754A Tonic food capable of lowering blood lipoid, resisting senility and regulating immunity |
| 06/06/2001 | CN1297749A External use medicine composition for promoting blood circulation and relieving pain |
| 06/06/2001 | CN1297745A Medicine for treating fracture and traumatic injury |
| 06/06/2001 | CN1297740A Compound medicine for migraine |
| 06/06/2001 | CN1297737A Preparation of medicine for restoring the normal transmitting function of nerve |
| 06/06/2001 | CN1297736A AIDS resisting medicine and its application |
| 06/06/2001 | CN1297702A Gamma-linolenic acid replenishing additive for food, medicine and cosmetics |
| 06/06/2001 | CN1066735C Cephalosporin antibiotics |
| 06/06/2001 | CN1066734C Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/06/2001 | CN1066733C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 06/06/2001 | CN1066732C Pyrido (2,3-b) pyrazine derivatives |
| 06/06/2001 | CN1066729C Benzimidazole derivatives, their producing process and its therapeutic use |
| 06/06/2001 | CN1066728C Process for producing epoxide |
| 06/06/2001 | CN1066727C Anti-migraine indole derivative salts |
| 06/06/2001 | CN1066726C 吡咯衍生物 Azole derivatives |
| 06/06/2001 | CN1066725C Optically active thiazolidinone derivatives |
| 06/06/2001 | CN1066720C Process for producing pharmaceutically active CNS compounds |
| 06/06/2001 | CN1066719C Process for producing pharmaceutically active CNS compounds |
| 06/06/2001 | CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use |
| 06/06/2001 | CN1066625C Therapeutical use for benzopyran derivative |
| 06/06/2001 | CN1066624C Dry mix formulation for bisphosphonic acids |
| 06/06/2001 | CA2328553A1 Novel derivatives (dihydro)benzoxazine and (dihydro)benzothiazine substitutes, process for preparing them and pharmaceutical compositions containing them |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 06/05/2001 | US6242619 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function |
| 06/05/2001 | US6242616 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 06/05/2001 | US6242614 10-deacetylbaccatin-iii which is protected at the 7-position with a dialkylalkoxysilyl protecting group; antitumor agents |
| 06/05/2001 | US6242611 Phenylimidazolidines containing nitrooxy or carbonyloxy groups |
| 06/05/2001 | US6242610 Reacting phenylmethyl 5-(6,8-diaza-6-(2-x-acetyl)-7-oxo-3-thiabicyclo(3.3.0)oct-2-yl)pentanoate with hiv protease to reduce the activity of the protease |
| 06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
| 06/05/2001 | US6242601 Heterocyclic sulfamides |
| 06/05/2001 | US6242596 Preparation of betamethyl carbapenem intermediates |
| 06/05/2001 | US6242594 Process for glucan preparation and therapeutic uses of glucan |
| 06/05/2001 | US6242590 Antisense modulation of zinc finger protein-217 expression |
| 06/05/2001 | US6242589 Phosphorothioate oligonucleotides having modified internucleoside linkages |
| 06/05/2001 | US6242583 Coupling carbohydrate compounds in presence of promoter to a functionalized solid support |
| 06/05/2001 | US6242578 Glycoconjugate of carbohydrate covalently bound to peptide of defined amino acid sequence; prevention of influenza virus binding to cells, treatment of schizophrenia, and diagnosis of chronic viral diseases related to cancer |
| 06/05/2001 | US6242497 Use of 6,7-substituted 2-aminotetralines suitable for preparing a pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 06/05/2001 | US6242492 N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid in iron chelating therapy |
| 06/05/2001 | US6242491 Administering creatine phosphate for wrinkle, aging, and solar radiation resistance and as free radical scavenger |
| 06/05/2001 | US6242490 Use of creatine |
| 06/05/2001 | US6242488 Method for preventing and treating pain |
| 06/05/2001 | US6242486 Long chain carboxybetaines in antimicrobial formulations |
| 06/05/2001 | US6242485 Administering prostanoic acid derivative to treat vision, kidney, cardiovascular and brain disorders; hypotensive and antiasthmatic agents |
| 06/05/2001 | US6242484 Hypoestoxides, derivatives and agonists thereof for use of antiparasitic agents |
| 06/05/2001 | US6242483 Selectively cytotoxic acetogenin compounds |
| 06/05/2001 | US6242482 Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure |
| 06/05/2001 | US6242481 Administering cytochalasin derivative as anticarcinogenic or antitumor agent |
| 06/05/2001 | US6242480 Ophthalmic viscoelastic compositions |
| 06/05/2001 | US6242479 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/05/2001 | US6242478 Five member ring sulfenate esters and thiosulfinate esters |
| 06/05/2001 | US6242477 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds |
| 06/05/2001 | US6242476 Leukotriene A4 hydrolase inhibitors |
| 06/05/2001 | US6242473 Administering histamine |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242469 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 06/05/2001 | US6242468 Carbamate and urea compositions and neurotrophic uses |
| 06/05/2001 | US6242467 Compounds |
| 06/05/2001 | US6242465 Mixture with fungicide, viricide, bactericide, antitumor agent, antihistamine, and/or serotonin reuptake inhibitor; nervous system and psychological disorders; antiemetics |